NCT01716169

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 7 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test the effectiveness of Helicoll (a collagen wound dressing) in treating chronic and non-chronic wounds of recessive dystrophic epidermolysis bullosa (RDEB) patients. Helicoll will be compared to standard wound dressings.

Conditions

• Epidermolysis Bullosa Dystrophica
• Epidermolysis Bullosa

Interventions

Type	Name	Description
DEVICE	Helicoll	Helicoll Collagen I Wound Dressing
DEVICE	Standard of Care Dressings	Standard of Care wound dressings (e.g. Vaseline gauze)

Timeline

• Start date: 2012-10-01
• Primary completion: 2013-11-01
• Completion: 2013-11-01
• First posted: 2012-10-29
• Last updated: 2016-05-05
• Results posted: 2016-05-05

Locations

1 site across 1 country: United States